
Curcumin in turmeric shows heart-protection promise for diabetes in rat study
A Florida Institute of Technology study using a Type 1 diabetes rat model finds curcumin—the active compound in turmeric—reduces inflammation, improves vascular function, and boosts a diabetes-affected protein, with treated rats resembling non-diabetic controls after a month. While promising, researchers caution it is far from a diabetes treatment in humans due to poor gut absorption; bioavailability can be improved with ingredients like black pepper, and more studies are needed to determine effective dosing. The findings were set to be presented at the American Physiology Summit.











